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Electrophoretic mobility shift assay
A B S T R A C T
Normal function and abnormal aggregation of transactivation response (TAR) DNA/RNA-binding protein 43 kDa
(TDP-43) are directly associated with the lethal genetic diseases: cystic ﬁbrosis, amyotrophic lateral sclerosis
(ALS), and frontotemporal lobar degeneration (FTLD). The binding of TDP-43 to single-stranded DNA (ssDNA) or
RNA is involved in transcriptional repression, regulation of RNA splicing, and RNA stabilization. Equilibrium
dissociation constants (Kd) of TDP-43 and ssDNA or RNA have been determined using various methods; however,
methods that can measure Kd with high sensitivity in a short time using a small amount of TDP-43 in solution
would be advantageous. Here, in order to determine the Kd of TDP-43 and ﬂuorescence-labeled ssDNA as well as
the binding stoichiometry, we use ﬂuorescence correlation spectroscopy (FCS), which detects the slowed dif-
fusion of molecular interactions in solution with single-molecule sensitivity, in addition to electrophoretic
mobility shift assay (EMSA). Using tandem aﬃnity chromatography of TDP-43 dually tagged with glutathione-S-
transferase and poly-histidine tags, highly puriﬁed protein was obtained. FCS successfully detected speciﬁc in-
teraction between puriﬁed TDP-43 and TG ssDNA repeats, with a Kd in the nanomolar range. The Kd of the TDP-
43 mutant was not diﬀerent from the wild type, although mutant oligomers, which did not bind ssDNA, were
observed. Analysis of the ﬂuorescence brightness per dimerized TDP-43/ssDNA complex was used to evaluate
their binding stoichiometry. The results suggest that an assay combining FCS and EMSA can precisely analyze
ssDNA recognition mechanisms, and that FCS may be applied for the rapid and quantitative determination of the
interaction strength between TDP-43 and ssDNA or RNA. These methods will aid in the elucidation of the
substrate recognition mechanism of ALS- and FTLD-associated variants of TDP-43.
1. Introduction
Transactivation response (TAR) DNA/RNA-binding protein 43 kDa
(TDP-43, encoded by TARDBP) is a ubiquitously expressed protein, and
its normal function and abnormal aggregation are directly associated
with the lethal genetic disease cystic ﬁbrosis, as well as two devastating
neurodegenerative disorders: amyotrophic lateral sclerosis (ALS) and
Tau-negative and TDP-43-positive frontotemporal lobar degeneration
(FTLD-TDP) [1–3]. TDP-43 was ﬁrst characterized as a transcriptional
repressor bound to the TAR DNA sequence of the gene of HIV-1 [4].
TDP-43 also acts as a splicing factor, binding to the intron 8/exon 9
junction of the cystic ﬁbrosis transmembrane conductance regulator
(CFTR) gene [5]. TDP-43 prefers to bind TG-rich single-stranded DNA
(ssDNA) or UG-rich RNA [6–8]. The sequence preference of TDP-43 for
UG repeats in the splice sites of various pre-mRNA transcripts, such as
POLDIP3/SKAR, sortilin 1, and DNAJC5, regulates exon exclusion and
inclusion [6,7,9]. Interactions between TDP-43 and microRNAs/small
RNAs maintain their stability and processing [10,11].
The cytoplasmic accumulation of TDP-43 aggregates in inclusion
bodies (IBs) has been observed in motor neurons from patients with ALS
and FTLD [12]. Many ALS- and FTLD-associated missense mutations,
which cause amino acid substitutions, have been identiﬁed in the
TARDBP gene [3]. These TDP-43 mutants are intimately involved in the
onset and severity of ALS and FTLD. The ALS-associated mutation
(A315T) promotes the formation of aggregates, leading to motor neuron
loss [13]. In addition, TDP-43 knockdown increases the proportion of
neuronal cell death [11]. Therefore, two hypotheses for motor neuron
cell death, due to TDP-43 aggregates harboring cytotoxicity or loss of
TDP-43 function, have been proposed [6,14].
TDP-43 carries 2 RNA/DNA-recognition motifs (RRM1 and RRM2)
and a C-terminal glycine-rich region (GRR) including the prion-like
intrinsically disordered region (IDR; also called the low complexity
sequence domain), which regulates interactions with proteins (e.g.,
heterogeneous nuclear ribonucleoprotein A1/A2 and FUS RNA binding
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protein). TDP-43 dimerization via the N-terminal ubiquitin-like domain
(NTD) has been reported [15].
The equilibrium dissociation constants (Kd) between TDP-43 and
various ssDNA and RNA have been determined using cross-linking and
immunoprecipitation followed by electrophoretic mobility shift assay
(EMSA) [16], nitrocellulose ﬁlter binding assay [17], ﬂuorescence
quenching [18], surface plasmon resonance [19], and isothermal ti-
tration calorimetry [20]. The Kd value of full-length TDP-43 or its RRMs
with RNA containing 6 UG repeats is several nM, and decreases as the
chain length increases [17,18]. However, the binding stoichiometry
between TDP-43 and nucleic acids remains unclear. Moreover, estab-
lishment of a procedure that can rapidly measure Kd in a solution even
with a low yield protein such as TDP-43 is useful in the analysis of the
binding state between TDP-43 and nucleic acids. Hence, we calculated
the Kd between TDP-43 and single-stranded 12 TG repeat ssDNA, and
determined the binding stoichiometry using ﬂuorescence correlation
spectroscopy (FCS), which can determine Kd and molecular brightness
per single particle with single molecule sensitivity.
2. Materials & methods
2.1. Protein expression and puriﬁcation
Escherichia coli BL21(DE3) cells carrying plasmids coding wild type
(WT) or ALS-associated A315T mutant (AT) TDP-43 tagged with glu-
tathione S-transferase (GST) at the N-terminus and poly-histidine (6×
His) at the C-terminus (GST-TDP-43-His; Fig. 1A) were cultured in
2×YT medium containing 100 μg/mL ampicillin at 37 °C. When the
optical density reached 0.45–0.5, the cells were cultured in medium
containing 0.5mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for
2 h at 18 °C to induce protein expression. Harvested cells were lysed in
buﬀer A (50mM HEPES-KOH (pH 7.5), 150mM NaCl, and 1mM
dithiothreitol (DTT)) containing 0.1% Triton-X 100 and protease in-
hibitor cocktail (TaKaRa, Shiga, Japan), and ultracentrifuged at
40,000 rpm for 1 h at 4 °C. The soluble fractions were recovered and
transferred to glutathione sepharose columns (GSTrap HP; GE Health-
care, Chicago, IL, USA) in AKTA prime system (GE Healthcare). The
columns were washed with buﬀer A and eluted in buﬀer A containing
10mM reduced glutathione. The eluted solutions were transferred to
nickel-nitrilotriacetic acid (Ni-NTA) columns (HisTrap HP; GE Health-
care) and washed in buﬀer A containing 20mM imidazole; and then
proteins were eluted in buﬀer A containing 500mM imidazole. The
buﬀer was replaced with 50mM HEPES-KOH (pH 7.5) using a cen-
trifugal dialysis ﬁlter (Amicon Ultra; Merck, Darmstadt, Germany), then
1% NP-40 was added if necessary.
2.2. FCS
FCS measurements were performed using a ConfoCor 2 system
combined with an LSM 510 META confocal laser scanning microscope
(Carl Zeiss, Jena, Germany) through a C-Apochromat 40×/1.2 NA Korr
UV-VIS-IR water-immersion objective (Carl Zeiss). The confocal pinhole
diameter was adjusted to 90 µm. Alexa Fluor 647 was excited at 633 nm
and emission was detected using a 650-nm long-pass ﬁlter.
Measurements were performed in a cover-glass chamber (#155411,
Thermo Fisher Scientiﬁc, Waltham, MA) after mixing puriﬁed TDP-43
with 3.3 nM Alexa Fluor 647-labeled ssDNA carrying 12 TG repeats
(TG12) or 20 T repeats (T20), synthesized by Thermo Fisher Scientiﬁc.
The obtained ﬂuorescence autocorrelation function (ACF), G(τ) (in
which the lag time (τ), was analyzed using a two-component diﬀusion
model including the exponential relaxation state derived from dynamic
ﬂuorescence quenching, mainly accompanied with intersystem crossing
between triplet and singlet state and photo-induced cis-trans iso-
merization of the Alexa Fluor 647 dye [21]) was given by Eq. (1):
Fig. 1. Single-strand DNA-binding activity of puriﬁed TDP-43. (A) Primary structure of TDP-43 tagged with glutathione S-transferase (GST) and a 6× poly-
histidine tag. NTD: N-terminal domain, RRM1/2: RNA/DNA-recognition motif 1/2, GRR: glycine-rich region (including the Q/N-rich and prion-like region). (B)
Puriﬁcation of wild type (WT) and ALS-associated A315T (AT) mutant GST-TDP-43-His using SDS-PAGE and silver staining. GST column elutes (lanes 1 & 3) and
subsequent Ni-NTA column elutes (lanes 2 & 4) are shown. Arrowheads indicate GST-TDP-43-His. (C) Fluorescent and silver stained gel images. GST-TDP-43-His
migration in the presence of TG12 (TG) or T20 (TT), and ssDNAs are shown. Molecular weights were determined from the migration of bovine serum albumin
monomers, dimers, and trimers, as indicated on the right. The migrated positions of ssDNA and TDP-43 are indicated by bands I–VII. *, auto-ﬂuorescence of
bromophenol blue.
A. Kitamura et al. Biochemistry and Biophysics Reports 14 (2018) 58–63
59





























































where τfree and τbound are the diﬀusion times of free and bound mole-
cules, respectively; Fbound denotes the binding fraction of Alexa Fluor
647-labeled ssDNAs; N is the average number of ﬂuorescent ssDNAs in
the confocal detection volume, deﬁned by the beam waist w0 and the
axial radius z0; s is a structure parameter representing the ratio of w0
and z0; T is the exponential relaxation fraction; and τRelax is the re-
laxation time of the state. G(τ) values were measured for 70 s. Fol-
lowing pinhole adjustment, the diﬀusion time (τRh6G) and structure
parameter (s) were determined using 0.1 μM Rhodamine 6 G (Rh6G) as
a standard prior to measurements. The w0 was determined using Eq.
(2).
= ∙w D τ40 Rh6G Rh6G (2)
where τRh6G is the measured diﬀusion time of Rh6G, and DRh6G is the
diﬀusion coeﬃcient of Rh6G (414 µm2/s). The volume element Veﬀ was
calculated using Eq. (3).
=V π w zeff 2/3 02 0 (3)
Counts per particle (CPP) values, each indicating the ﬂuorescence





where< I> indicates the mean count rate.
2.3. Calculation of the apparent dissociation constant







where, [Proteinfree] is the concentration of unbound protein, [ssDNAfree]
is the concentration of unbound ssDNA, and [Complex] is the con-
centration of the complex, as per Eqs. 6, 7, and 8.
= ⋅ ⋅ ⋅− −Complex F N N V[ ] bound A eff1 1 (6)
= −ssDNA ssDNA Complex[ ] [ ] [ ]free total (7)
= −Protein Protein Complex[ ] [ ] [ ]free total (8)
where NA is Avogadro constant, [ssDNAtotal] was obtained from FCS,
and [Proteintotal] was obtained from the bovine serum albumin (BSA)
calibration curve using silver staining.
2.4. EMSA
Alexa Fluor 647-labeled ssDNA (TG12 or T20) was combined with
either puriﬁed TDP-43 in a sample buﬀer containing 50mM HEPES-
KOH (pH 7.5) and 10% glycerol or with buﬀer alone, and resolved on
7.5% polyacrylamide gels including 375mM HEPES-KOH (pH 7.5).
Electrophoresis was performed in a running buﬀer including 35mM
HEPES and 43mM imidazole at 120 V and 4 °C. After the infrared
ﬂuorescence of the ssDNAs in the gels was captured using a Typhoon
ﬂuorescence image scanner (Thermo Fisher Scientiﬁc), TDP-43 in the
gel was visualized using silver staining (Cosmo Bio Co. Ltd., Tokyo,
Japan).
3. Results
3.1. Puriﬁcation of recombinant TDP-43 possessing single-strand DNA
(ssDNA)-binding ability
We initially attempted to purify GST-TDP43WT-His (TDP-43WT)
using the GST tag; however, the sample eluted from the glutathione
sepharose column included many fragments of TDP-43WT in addition
to the full-length protein (Fig. 1B, lane 1). We therefore further puriﬁed
the protein by Ni-NTA sepharose aﬃnity chromatography. Tandem
aﬃnity chromatography successfully produced highly puriﬁed TDP-
43WT (Fig. 1B, lane 2) as well as GST-TDP43-A315T-His (TDP-43AT)
(Fig. 1B, lanes 3 & 4). These results indicated that the fragments of TDP-
43 truncated at the C-terminus. Truncation patterns between the WT
and AT mutant proteins were not changed.
To conﬁrm whether the puriﬁed TDP-43 proteins were correctly
folded, their speciﬁc ssDNA (TG repeat)-binding ability was examined
using EMSA. TG12 migrated more slowly in the presence of WT or AT
mutant TDP-43 than in their absence (bands III, V, and VI; Fig. 1C, lanes
1, 2, 9, and 10), whereas T20 migration was not slowed in the presence
of TDP-43 (band VII; Fig. 1C, lanes 3, 4, 11, and 12). Band III was
observed in the silver stained gel, whereas bands V and VI were not
(Fig. 1C, lanes 6 and 14), indicating that band III is the TDP-43/TG12
complex, and that a portion of TG12 may have dissociated during
electrophoresis. These results conﬁrmed that both WT and AT mutant
TDP-43 maintained speciﬁc ssDNA-binding ability.
3.2. Determination of the Kd between TDP-43 and ssDNA
To observe interactions between TDP-43 and ﬂuorescence-labeled
ssDNA in solution, we employed FCS, which can detect molecular in-
teractions by measuring the apparent increased molecular weight of
low molecular weight ﬂuorescent molecules though their decreased
diﬀusion speed when bound to high molecular weight species in solu-
tion with single molecule sensitivity [22,23]. The autocorrelation
functions (ACFs) of TG12 were shifted to the right in the presence of
puriﬁed WT and AT mutant TDP-43, whereas those of T20 were not
(Fig. 2), indicating speciﬁc interactions between puriﬁed TDP-43 and
TG12.
Next, to quantify the interaction strength between TDP-43 and
TG12, we calculated Kd values using FCS. Complex and unbound mo-
lecule concentrations were obtained through FCS measurement of each
sample and calculated using Eqs. 6, 7, and 8, and linear regression
calculations were performed to determine the ﬁtting line through each
scatter plot. Kd values were calculated from the slope of the regression
line. The Kd value between TDP-43WT and TG12 in the absence of NP-
40, a detergent, did not diﬀer from that of the AT mutant 237 ± 39.4
and 289 ± 21.4 nM, respectively; slope value± standard error of the
mean (SEM; Fig. 3A). Although the Kd values of WT and AT TDP-43
with TG12 were decreased in the presence of NP-40 (90.0 ± 5.3 and
89.2 ± 6.0 nM, respectively), diﬀerences between the WT and AT
mutant proteins were not observed (Fig. 3B). Moreover, the Kd value
between TDP-43 wt and TG12 in the absence of NP-40 was dramatically
increased after storage at 4 °C for 1 day after the puriﬁcation; however,
in presence of NP-40, the Kd value was not changed in the same storage
conditions (Supplemental Figure), suggesting that NP-40 stabilized
TDP-43. These results suggest that the ssDNA-binding ability of wild
type TDP-43 may not diﬀer from that of the ALS-associated A315T
mutant of TDP-43, and that this ability may be involved in the active
structure of TDP-43.
3.3. Stoichiometry of TDP-43/ssDNA binding
Three migration patterns for puriﬁed TDP-43 were observed when
not bound to ssDNA (bands I, II, and IV, Fig. 1C, lanes 8 and 16). The
migration of band IV corresponded to that of BSA dimers (132.6 kDa;
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Fig. 2. Autocorrelation functions (ACFs) of ﬂuorescently labeled ssDNA in the presence and absence of puriﬁed TDP-43. Normalized ACFs of Alexa Fluor
647-labeled TG12 (TG; A & C) or T20 (TT; B & D) in 50mM HEPES-KOH buﬀer without NP-40 are shown in the presence and absence of wild type TDP-43 (WT;
42.1 ng) or the A315T mutant (AT; 67.5 ng; magenta and green, respectively).
Fig. 3. Determination of the TG12/TDP-43 dissociation constant using FCS. (A and B) Kd determinations using scatter plots and linear regression in the absence
(A) or presence (B) of NP-40. The plot represents the concentration of free TG12 and TDP-43 versus the concentration of the TDP-43/TG12 complex. The red and blue
solid dots show each measurement result for wild type and A315T mutant, respectively. The sample size: (A) wild type (n= 24) and A315T (n=18), (B) wild type
(n=12) and A315T (n=17). The red and blue solid lines show the linear ﬁt for wild type and A315T mutant TDP-43, respectively. The slope represents the Kd, and
inset values represent the slope± SEM. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article)
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Fig. 1C, lanes 8 and 16), and the theoretical monomeric molecular
weight of GST-tagged TDP-43 was 73.5 kDa; thus, TDP-43 migrated as a
dimer. TDP-43 migrated more slowly than BSA trimers (band II; Fig. 1C,
lanes 8 and 16), suggesting that a portion of TDP-43 may form tetra-
mers or higher order multimers. Moreover, the intensity of the band of
TDP-43AT at the initial sample loading point (band I) was increased
comparing to that of wild type, suggesting that TDP-43AT has a greater
tendency to oligomerize compared to the WT protein. Since TG12 was
not found in the electrophoresis position of these TDP-43 oligomers
(bands I and II), they may be aggregated. The estimated molecular
weight of the TDP-43-TG12 complex (band III) corresponded to that of
BSA trimers (198.9 kDa). Therefore, the TDP-43-TG12 complex included
TDP-43 dimers.
FCS analysis can determine the mean ﬂuorescence brightness per
particle (CPP); thus, it is possible to investigate the number of ssDNAs
contained in the TDP-43-TG12 complex. The CPP values of TG12 in the
presence of WT or AT mutant TDP-43 were signiﬁcantly higher than
those in absence of TDP-43 (Fig. 4). FCS analysis using a two-compo-
nent diﬀusion model indicated that the proportion of the TDP-43-TG12
complex was approximately 40%, which corresponds to that calculated
from the increase CPP ratio, assuming that the TDP-43 dimers include
two molecules of TG12. Therefore, the TDP-43-TG12 complex including
TDP-43 dimers may exist predominantly in a 1:1 ratio.
4. Discussion
We have successfully determined the apparent Kd between re-
combinant full-length TDP-43 and TG ssDNA repeat using FCS in so-
lution and EMSA, providing a high accuracy molecular weight separa-
tion method. Although various determinations of the Kd between TDP-
43 and RNA/DNA using biochemical or ﬂuorescence-based methods
have been reported, using FCS allows the Kd to be rapidly measured in a
native solution state. The Kd between recombinant full-length TDP-43
and 6 UG repeat RNA, calculated using the ﬂuorescence quenching of
TDP-43 as a titration of the RNA, was reported to be several nM
[18,24], lower than our result in spite of the use of a longer twelve TG
repeat DNA (~90 nM in the presence of NP-40; Fig. 3B). This may be
because only a portion of TDP-43 is bound to TG12. In fact, taking into
account that approximately 50% of the TDP-43 bound to ssDNA ac-
cording to EMSA, and the ~8-fold higher Kd of the TDP-43 RRM with
DNA compared with RNA [17], the corrected Kd corresponds to
~5.6 nM. Therefore, the Kd value was not inferior to the obtained value
using FCS. Otherwise, in the previous work, TDP-43 oligomers might
bind with TG12 more stable than dimers depending on diﬀerent ex-
pression and puriﬁcation condition, causing the much lower Kd.
We found that NP-40 stabilized the puriﬁed TDP-43. The binding
activity of TDP-43 was decreased in the absence of NP-40 with un-
changed concentration 1 d after the puriﬁcation (Supplemental Figure),
suggesting that the deactivation of ssDNA binding ability is not due to
fragmentation and degradation of the protein. The stabilization of TDP-
43 through inter-domain interactions and the adoption of a closed
conformation, as well as self-assembly of the C-terminal IDR at neutral
pH, have been reported [25,26]. NP-40 may stabilize the TDP-43
structure by preventing C-terminal IDR self-assembly even at neutral
pH.
The Kd value of the ALS-associated A315T mutant of TDP-43 was
not diﬀerent from that of the WT (Fig. 3, A and B). Although the
binding aﬃnity of TDP-43 to UG/TG-rich RNA/DNA is mainly mediated
through the RRM [8,16,17], NMR analysis shows that the C-terminal
IDR and NTD of TDP-43 can bind to TG repeat ssDNA. Thus, the C-
terminal IDR and NTD of TDP-43 may be secondarily involved in
binding RNA/DNA, possibly by capturing long nucleic acid strands
bound to the RRM. In fact, TDP-43 carrying the M337V mutation binds
weakly to PSD-95 and CaMKIIa mRNA [19]. Therefore, the ALS-asso-
ciated mutations in the C-terminal IDR may not dramatically aﬀect
binding aﬃnity to short nucleic acid strands; however, they would af-
fect binding to long nucleic acid strands such as mRNAs or long non-
coding RNAs.
The multimerization of TDP-43 in mammalian cells as well as in
solution has been reported [27–29]. Dimerization occurs though
homodimerization of the TDP-43 NTD [30]. However, it is diﬃcult to
distinguish dimers, trimers, and higher multimers in sample due to the
propensity of TDP-43 to aggregate. Our established puriﬁcation system
provides recombinant TDP-43 with good solubility and ssDNA-binding
ability, and demonstrates that a portion of TDP-43 forms dimers, and
that two ssDNAs bind to each dimer. Thus, the interaction stoichio-
metry between TDP-43 dimers and ssDNA appears to be 1:1.
Finally, we established a rapid measurement system at the uL scale
using nM levels of puriﬁed TDP-43 and ﬂuorescently labeled nucleic
acids by FCS. This system can be applied to high throughput and
quantitative determinations of interactions between TDP-43 and ssDNA
or RNA to elucidate the substrate recognition mechanism of ALS-asso-
ciated TDP-43.
Acknowledgements
A.K. was supported by a Japan Society for Promotion of Science
(JSPS) Grant-in-Aid for the Promotion of Joint International Research
(Fostering Joint International Research) (16KK0156); a JSPS Grant-in-
Aid for Scientiﬁc Research (C) (#26440090); by a grant-in-aid from The
Nakabayashi Trust for ALS research (Tokyo, Japan); by a grant-in-aid
from the Japan Amyotrophic Lateral Sclerosis Association (JALSA,
Tokyo, Japan) for ALS research, and by a grant from the Akiyama Life
Science Foundation (Sapporo, Japan).
Author contributions
Conceived and designed the experiments: AK. Developed the protein
puriﬁcation: AK, AS, and RS. Developed measurement conditions to
detect protein-DNA interactions: AK and AS. Performed the ﬂuores-
cence correlation spectroscopy: AK, AS, and KT. Analyzed the data: AK,
AS, KT, and MK. Wrote the paper: AK and MK.
Appendix A. Transparency document
Supplementary data associated with this article can be found in the
Fig. 4. Binding stoichiometry of TDP-43 and ssDNA. Normalized counts per
particle (CPP) values of Alexa Fluor 647-labeled TG12 in the presence of TDP-43
(mean± SEM; n= 3). The dotted line indicates the CPP value in the absence of
TDP-43. Student's t-test was used to compare values in the presence and absence
of TDP-43; * p < 0.05 and **p< 0.01. No signiﬁcant diﬀerence: ns.
A. Kitamura et al. Biochemistry and Biophysics Reports 14 (2018) 58–63
62
online version at http://dx.doi.org/10.1016/j.bbrep.2018.03.009.
References
[1] E. Buratti, F.E. Baralle, The multiple roles of TDP-43 in pre-mRNA processing and
gene expression regulation, RNA Biol. 7 (2010) 420–429.
[2] A. Ratti, E. Buratti, Physiological functions and pathobiology of TDP-43 and FUS/
TLS proteins, J. Neurochem. 138 (Suppl 1) (2016) 95–111.
[3] C. Lagier-Tourenne, M. Polymenidou, D.W. Cleveland, TDP-43 and FUS/TLS:
emerging roles in RNA processing and neurodegeneration, Hum. Mol. Gen. 19
(2010) R46–R64.
[4] S.H. Ou, F. Wu, D. Harrich, L.F. Garcia-Martinez, R.B. Gaynor, Cloning and char-
acterization of a novel cellular protein, TDP-43, that binds to human im-
munodeﬁciency virus type 1 TAR DNA sequence motifs, J. Virol. 69 (1995)
3584–3596.
[5] E. Buratti, T. Dork, E. Zuccato, F. Pagani, M. Romano, F.E. Baralle, Nuclear factor
TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping, EMBO
J. 20 (2001) 1774–1784.
[6] M. Polymenidou, C. Lagier-Tourenne, K.R. Hutt, S.C. Huelga, J. Moran, T.Y. Liang,
S.C. Ling, E. Sun, E. Wancewicz, C. Mazur, H. Kordasiewicz, Y. Sedaghat,
J.P. Donohue, L. Shiue, C.F. Bennett, G.W. Yeo, D.W. Cleveland, Long pre-mRNA
depletion and RNA missplicing contribute to neuronal vulnerability from loss of
TDP-43, Nat. Neurosci. 14 (2011) 459–468.
[7] J.R. Tollervey, T. Curk, B. Rogelj, M. Briese, M. Cereda, M. Kayikci, J. Konig,
T. Hortobagyi, A.L. Nishimura, V. Zupunski, R. Patani, S. Chandran, G. Rot,
B. Zupan, C.E. Shaw, J. Ule, Characterizing the RNA targets and position-dependent
splicing regulation by TDP-43, Nat. Neurosci. 14 (2011) 452–458.
[8] P.H. Kuo, C.H. Chiang, Y.T. Wang, L.G. Doudeva, H.S. Yuan, The crystal structure of
TDP-43 RRM1-DNA complex reveals the speciﬁc recognition for UG- and TG-rich
nucleic acids, Nucleic Acids Res. 42 (2014) 4712–4722.
[9] A. Shiga, T. Ishihara, A. Miyashita, M. Kuwabara, T. Kato, N. Watanabe,
A. Yamahira, C. Kondo, A. Yokoseki, M. Takahashi, R. Kuwano, A. Kakita,
M. Nishizawa, H. Takahashi, O. Onodera, Alteration of POLDIP3 splicing associated
with loss of function of TDP-43 in tissues aﬀected with ALS, PLOS One 7 (2012)
e43120.
[10] Y. Kawahara, A. Mieda-Sato, TDP-43 promotes microRNA biogenesis as a compo-
nent of the Drosha and Dicer complexes, Proc. Natl. Acad. Sci. USA 109 (2012)
3347–3352.
[11] M. Yahara, A. Kitamura, M. Kinjo, U6 snRNA expression prevents toxicity in TDP-
43-knockdown cells, PLOS One 12 (2017) e0187813.
[12] M. Neumann, D.M. Sampathu, L.K. Kwong, A.C. Truax, M.C. Micsenyi, T.T. Chou,
J. Bruce, T. Schuck, M. Grossman, C.M. Clark, L.F. McCluskey, B.L. Miller,
E. Masliah, I.R. Mackenzie, H. Feldman, W. Feiden, H.A. Kretzschmar,
J.Q. Trojanowski, V.M. Lee, Ubiquitinated TDP-43 in frontotemporal lobar degen-
eration and amyotrophic lateral sclerosis, Science 314 (2006) 130–133.
[13] L. Bargsted, D.B. Medinas, F. Martinez Traub, P. Rozas, N. Munoz, M. Nassif,
C. Jerez, A. Catenaccio, F.A. Court, C. Hetz, S. Matus, Disulﬁde cross-linked mul-
timers of TDP-43 and spinal motoneuron loss in a TDP-43(A315T) ALS/FTD mouse
model, Sci. Rep. 7 (2017) 14266.
[14] Y.S. Fang, K.J. Tsai, Y.J. Chang, P. Kao, R. Woods, P.H. Kuo, C.C. Wu, J.Y. Liao,
S.C. Chou, V. Lin, L.W. Jin, H.S. Yuan, I.H. Cheng, P.H. Tu, Y.R. Chen, Full-length
TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar
dementia-TDP patients, Nat. Commun. 5 (2014) 4824.
[15] H. Qin, L.Z. Lim, Y. Wei, J. Song, TDP-43 N terminus encodes a novel ubiquitin-like
fold and its unfolded form in equilibrium that can be shifted by binding to ssDNA,
Proc. Natl. Acad. Sci. USA 111 (2014) 18619–18624.
[16] A. Bhardwaj, M.P. Myers, E. Buratti, F.E. Baralle, Characterizing TDP-43 interaction
with its RNA targets, Nucleic Acids Res. 41 (2013) 5062–5074.
[17] P.H. Kuo, L.G. Doudeva, Y.T. Wang, C.K. Shen, H.S. Yuan, Structural insights into
TDP-43 in nucleic-acid binding and domain interactions, Nucleic Acids Res. 37
(2009) 1799–1808.
[18] W. Li, A.N. Reeb, B. Lin, P. Subramanian, E.E. Fey, C.R. Knoverek, R.L. French,
E.H. Bigio, Y.M. Ayala, Heat shock-induced phosphorylation of TAR DNA-binding
protein 43 (TDP-43) by MAPK/ERK kinase regulates TDP-43 function, J. Biol.
Chem. 292 (2017) 5089–5100.
[19] A. Ishiguro, N. Kimura, Y. Watanabe, S. Watanabe, A. Ishihama, TDP-43 binds and
transports G-quadruplex-containing mRNAs into neurites for local translation,
Genes Cells 21 (2016) 466–481.
[20] P.J. Lukavsky, D. Daujotyte, J.R. Tollervey, J. Ule, C. Stuani, E. Buratti, F.E. Baralle,
F.F. Damberger, F.H. Allain, Molecular basis of UG-rich RNA recognition by the
human splicing factor TDP-43, Nature Struct. Mol. Biol. 20 (2013) 1443–1449.
[21] J. Widengren, P. Schwille, Characterization of photoinduced isomerization and
back-isomerization of the cyanine dye Cy5 by ﬂuorescence correlation spectro-
scopy, J. Phys. Chem. A 104 (2000) 6416–6428.
[22] A. Kitamura, Y. Ishida, H. Kubota, C.G. Pack, T. Homma, S. Ito, K. Araki, M. Kinjo,
K. Nagata, Detection of substrate binding of a collagen-speciﬁc molecular cha-
perone HSP47 in solution using ﬂuorescence correlation spectroscopy, Biochemi.
Biophys. Res. Commun. 497 (2018) 279–284.
[23] R. Rigler, U. Mets, J. Widengren, P. Kask, Fluorescence correlation spectroscopy
with high count rate and low-background - analysis of translational diﬀusion, Eur.
Biophys. J. 22 (1993) 169–175.
[24] Y.M. Ayala, S. Pantano, A. D'Ambrogio, E. Buratti, A. Brindisi, C. Marchetti,
M. Romano, F.E. Baralle, Human, Drosophila, and C.elegans TDP43: nucleic acid
binding properties and splicing regulatory function, J. Mol. Biol. 348 (2005)
575–588.
[25] Y. Wei, L. Lim, L. Wang, J. Song, Inter-domain interactions of TDP-43 as decoded by
NMR, Biochem. Biophys. Res. Commun. 473 (2016) 614–619.
[26] L. Lim, Y. Wei, Y. Lu, J. Song, ALS-causing mutations signiﬁcantly perturb the self-
assembly and interaction with nucleic acid of the intrinsically disordered prion-like
domain of TDP-43, PLOS Biol. 14 (2016) e1002338.
[27] Y. Shiina, K. Arima, H. Tabunoki, J. Satoh, TDP-43 dimerizes in human cells in
culture, Cell. Mol. Neurobiol. 30 (2010) 641–652.
[28] C. Foglieni, S. Papin, A. Salvade, T. Afroz, S. Pinton, G. Pedrioli, G. Ulrich,
M. Polymenidou, P. Paganetti, Split GFP technologies to structurally characterize
and quantify functional biomolecular interactions of FTD-related proteins, Sci. Rep.
7 (2017) 14013.
[29] T. Afroz, E.M. Hock, P. Ernst, C. Foglieni, M. Jambeau, L.A.B. Gilhespy,
F. Laferriere, Z. Maniecka, A. Pluckthun, P. Mittl, P. Paganetti, F.H.T. Allain,
M. Polymenidou, Functional and dynamic polymerization of the ALS-linked protein
TDP-43 antagonizes its pathologic aggregation, Nat. Commun. 8 (2017) 45.
[30] L.L. Jiang, W. Xue, J.Y. Hong, J.T. Zhang, M.J. Li, S.N. Yu, J.H. He, H.Y. Hu, The N-
terminal dimerization is required for TDP-43 splicing activity, Sci. Rep. 7 (2017)
6196.
A. Kitamura et al. Biochemistry and Biophysics Reports 14 (2018) 58–63
63
